| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 03/11/2010 | US20100062975 Method for the treatment and prevention of ocular disorders |
| 03/11/2010 | US20100062537 Polypeptide Markers for the Diagnosis and Evaluation of Pelvi-Ureteric Junction Obstruction (PUJO) |
| 03/11/2010 | US20100062052 Peptide-based compounds as new inhibitors of metalloectopeptidases, compositions comprising said compounds and their pharmaceutical and cosmetic uses |
| 03/11/2010 | US20100062038 Markers, Antibodies and Recombinant scFvs for Mesenchymal Stem Cell Sub-populations and Osteoclasts |
| 03/11/2010 | US20100062010 Novel peptide compound |
| 03/11/2010 | US20100061991 Identification of therapeutic agents for HIV infection |
| 03/11/2010 | US20100061932 Peptides useful as cell-penetrating peptides |
| 03/11/2010 | US20100061929 Neoplasia targeting peptides and methods of using the same |
| 03/11/2010 | DE102008046610A1 Verwendung einer pharmazeutischen Zusammensetzung zur lokalen Infektionstherapie sowie Medizinprodukt Use of a pharmaceutical composition for local infection therapy and medical device |
| 03/11/2010 | CA2733943A1 Peptides presenting an epitope of an a domain of factor h binding protein and methods of use |
| 03/10/2010 | EP2161279A1 Synthetic peptides corresponding to overlapping neutralizing determinants in the CBD1 epitope induce broadly neutralizing antibodies |
| 03/10/2010 | EP2161037A2 Camptothecin-Somatostatin conjugates |
| 03/10/2010 | EP2160404A1 Azapeptides as cd36 binding compounds |
| 03/10/2010 | EP2160400A1 Peptides as antimicrobial agents towards campylobacter spp |
| 03/10/2010 | EP2160221A1 Cyclic peptide cxcr4 antagonists |
| 03/10/2010 | CN101665531A Lepista sordida protein LsAPII as well as preparation method and application thereof |
| 03/10/2010 | CN101665530A Antiphytoviral black pleurotus ostreatus protein as well as preparation method and application thereof |
| 03/10/2010 | CN101665529A Method for promoting solid phase synthesis of balsam pear MC-JJ22 polypeptide analogue by microwaves and application thereof |
| 03/10/2010 | CN101665528A Method for promoting solid phase synthesis of balsam pear MC-JJ2 polypeptide analogue by microwaves and application thereof |
| 03/09/2010 | US7674773 Glycosylated derivative of hypolipemic agents; side effect reduction; therapy for insulin resistance; hyperlipidemia agent; impaired lipid metabolism; lowering cholesterol levels |
| 03/09/2010 | US7674772 Compositions and methods for treating atherosclerosis |
| 03/09/2010 | US7674771 laminin binding site |
| 03/09/2010 | US7674768 Processes for preparing eptifibatide |
| 03/09/2010 | CA2342960C G protein-coupled receptor antagonists |
| 03/04/2010 | WO2010024927A2 Treatment of amyloidoses using myelin basic protein and fragments thereof |
| 03/04/2010 | WO2010024269A1 Dwarf transgenic plant, and gene for induction of dwarfing |
| 03/04/2010 | WO2010024262A1 Transfection agent |
| 03/04/2010 | WO2010024108A1 Prophylactic or therapeutic agent for influenza virus infection |
| 03/04/2010 | WO2010023838A1 Tbc1d7 as tumor marker and therapeutic target for cancer |
| 03/04/2010 | WO2010023346A1 Hybrid tripyrrole-octaarginine compounds and their use as medicament in the treatment of cancer and microbial illnesses |
| 03/04/2010 | WO2010023247A1 Synthetic peptides corresponding to overlapping neutralizing determinants in the cbd1 epitope induce broadly neutralizing antibodies. |
| 03/04/2010 | WO2010005515A3 Expression methods for guanylate cyclase c receptor binding polypeptides |
| 03/04/2010 | WO2009149094A3 Cytotoxic t cell defined egfr peptide and an optimized derivative peptide |
| 03/04/2010 | WO2009148230A3 Immunogenic peptide and composition containing the peptide for preventing or treating hpv-related diseases |
| 03/04/2010 | WO2009148229A3 Immunogenic peptide and composition containing the peptide for preventing or treating hpv-related diseases |
| 03/04/2010 | WO2009003284A8 Novel peptides, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same |
| 03/04/2010 | US20100056755 Process for Making Bivalirudin |
| 03/04/2010 | US20100056612 Molecular entities for binding, stabilization and cellular delivery of charged molecules |
| 03/04/2010 | US20100056459 Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway |
| 03/04/2010 | US20100056458 Peptides Inhibiting Angiotensin-Converting Enzyme |
| 03/04/2010 | US20100056457 Zinc Finger Binding Domains for CNN |
| 03/04/2010 | US20100056456 Omega Conotoxins |
| 03/04/2010 | US20100056446 NA+K+-ATPase-Specific Peptide Inhibitors/Activators of SRC and SRC Family Kinases |
| 03/04/2010 | US20100056433 Novel Peptides for Use in the Treatment of Obesity |
| 03/04/2010 | US20100056432 Template-fixed peptidomimetics with antibacterial activity |
| 03/04/2010 | US20100055146 Cyclic angiotensin analogs |
| 03/04/2010 | US20100055121 Brachyury polypeptides and methods for use |
| 03/04/2010 | US20100055119 Peptides sequences and compositions |
| 03/04/2010 | US20100055118 Peptidic Growth Hormone Secretagogues Analog Compounds and Preparations Thereof |
| 03/04/2010 | US20100055117 Allorestricted peptide-specific t cells |
| 03/04/2010 | CA2735182A1 Tbc1d7 as tumor marker and therapeutic target for cancer |
| 03/04/2010 | CA2732215A1 Synthetic peptides corresponding to overlapping neutralizing determinants in the cbd1 epitope induce broadly neutralizing antibodies |
| 03/03/2010 | EP2159229A1 High purity lipopeptides, lipopeptide micelles and processes for preparing same |
| 03/03/2010 | EP2157967A2 Suspension formulations of insulinotropic peptides and uses thereof |
| 03/03/2010 | CN101659694A Anti-tumor cyclic pentapeptide compound and preparation method thereof |
| 03/03/2010 | CN101659693A Method for preparing pneumocandin B0 |
| 03/03/2010 | CN101659692A Method for preparing echinocandin B |
| 03/02/2010 | US7671258 Surfactant peptide nanostructures, and uses thereof |
| 03/02/2010 | US7671176 host cells that contain an isolated nucleic acid molecule that encodes a polypeptide having mu3 opiate receptor activity; for identifying mu3 opiate receptor agonists and antagonists |
| 03/02/2010 | US7671175 animal feed additive; detergent; defensins; exhibit reduced hemolytic activity, cytotoxicity and sensitivity towards cations, such as Ca2+, Mg2+, Na+. |
| 03/02/2010 | US7671028 Peptides that antagonize FPR class receptor mediated signaling |
| 03/02/2010 | US7671021 Peptides that home to tumor lymphatic vasculature and methods of using same |
| 03/02/2010 | US7671011 peptide comprises at least two positively charged amino acid residues; the peptide after conjugation to the fatty acid possessing antibacterial, antifungal, and/or anticancer activity higher than prior to conjugation; suitable for treatment of infections caused by pathogenic organisms such as bacteria |
| 03/02/2010 | US7670852 very early marker of fertilization and embryo viability; binds to anti-CD2 antibody; Infertility |
| 03/02/2010 | US7670851 Assays for preimplantation factor and preimplantation factor peptides |
| 03/02/2010 | US7670850 Assays for preimplantation factor and preimplantation factor peptides |
| 03/02/2010 | CA2390659C Ny-eso-1 peptide derivatives, and uses thereof |
| 02/25/2010 | WO2010021961A2 Improved production of proteins with downstream box fusions in plastids and in bacteria |
| 02/25/2010 | WO2010021849A2 Recombinant fragments and synthetic peptides of 17-kda polypeptide useful in detecting bartonella henselae |
| 02/25/2010 | WO2009135118A3 Lyme disease vaccine |
| 02/25/2010 | US20100048865 Microwave-assisted peptide synthesis |
| 02/25/2010 | US20100048862 Ferroportin1 nucleic acids, proteins, antibodies and methods |
| 02/25/2010 | US20100048488 Immunomodulatory peptides |
| 02/25/2010 | US20100048487 Novel cell penetrating peptide |
| 02/25/2010 | US20100048482 Compositions and methods for modulating epsilon protein kinase c-mediated cytoprotection |
| 02/25/2010 | US20100048469 Antimicrobial peptides |
| 02/25/2010 | US20100048466 Compositions, Reagents and Kits for and Methods of Diagnosing, Monitoring and Treating Hormonal Imbalance |
| 02/25/2010 | US20100048464 Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same |
| 02/25/2010 | US20100048463 Template-fixed peptidomimetics |
| 02/25/2010 | US20100048462 Truncated pth peptides with a cyclic conformation |
| 02/25/2010 | US20100048459 Lantibiotic biosynthetic gene clusters from a. garbadinensis and a. liguriae |
| 02/25/2010 | US20100047895 Methods for purification of bacterial cells and cell components |
| 02/25/2010 | US20100047770 Detection of Breast Cancer |
| 02/25/2010 | US20100047275 Peptide sequences and compositions |
| 02/25/2010 | US20100047273 Coxsackie B virus and type 1 diabetes |
| 02/25/2010 | US20100047170 Peptide Prodrugs |
| 02/25/2010 | CA2734515A1 Inhbb epitope peptides and vaccines containing the same |
| 02/24/2010 | EP2157098A2 Peptides with capacity for binding with interleukine 10 (il - 10) |
| 02/24/2010 | EP2157097A1 Specific binding agents of human angiopoietin-2 |
| 02/24/2010 | EP2155872A1 Tem8 peptides and vaccines comprising the same |
| 02/24/2010 | EP2155226A2 Compounds for inhibiting protein aggregation, and methods for making and using them |
| 02/24/2010 | EP1572066B1 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2 |
| 02/24/2010 | EP1471936B1 Hiv vaccine and method of use |
| 02/24/2010 | CN101657465A Peptides, compositions and uses thereof |
| 02/24/2010 | CN101654476A Peptide-based body surface reagents for personal care |
| 02/24/2010 | CN101654475A Antigenic epitope of human tumor necrosis factor alpha and preparation method and application thereof |
| 02/24/2010 | CN101654474A Crohn's disease antibody epitope peptide and reagent for testing crohn's disease |
| 02/24/2010 | CN100591691C Anti-tumour compound |
| 02/23/2010 | US7666985 HLA-A24-restricted cancer antigen peptides |
| 02/23/2010 | US7666984 Consisting of the amino acid sequence ALFDGDPHL, the peptide having the ability to bind to a molecule of human major histocompatibility complex class-I; use in immunotherapy of tumor-associated diseases and/or adenomatous diseases |